Blood Drug Testing

Niacin Drug Test News

Woman Struggles to Control CholesterolMonday, July 11, 2011 @ 4:32AMTUESDAY, Dec. 28 (HealthDay News) -- Sheri Foote has cholesterol problems the likes of which few will ever have.

EMA CHMP recommends approval of linagliptin for type 2 diabetesFriday, June 24, 2011 @ 11:04AMBoehringer Ingelheim and Eli Lilly and Company today received a positive opinion from the European Medicines Agency's (EMA) medicinal committee recommending approval of linagliptin, 5 mg, film-coated tablets (to be marketed under the trade name Trajenta® in Europe) for the treatment of adults with type 2 diabetes.

ESC publishes position paper to raise the profile of vulnerable plaquesWednesday, June 15, 2011 @ 4:54AMThe European Society of Cardiology (ESC) Working Group of Atherosclerosis and Vascular Biology has published a position paper to raise the profile of vulnerable plaques and the need for greater use of therapies to promote plaque stabilisation.

Solana Health’s New Report Shows How to Lower Cholesterol Safely and Naturally for Adults, Teens, & ChildrenTuesday, May 31, 2011 @ 4:00PMSolana Health’s revealing How to Lower Cholesterol Naturally So You Can Live the Long, Happy Life You Deserve is a just-released free wellness report that details a 7-step approach for lowering LDL cholesterol and raising HDL cholesterol without prescription medication.

Five Lessons From Niaspan's Disappointing StudyTuesday, May 31, 2011 @ 6:41AMComparative effectiveness research -- investigations that determine which treatments are best -- has attracted attention in the health care debate. Critics charge that these studies are designed to restrict choice. The Center for Medicine in the Public Interest released a report that suggested that they would stifle innovation. Often they [...]

Study: 'Good' Cholesterol-Boosting Drug Fails to Reduce Heart Attacks, StrokesFriday, May 27, 2011 @ 7:45PMListen to the Audio JEFFREY BROWN: Next, the latest findings about how cholesterol drugs do and do not work. Margaret Warner has the story. MARGARET WARNER: Millions of Americans take two kinds of cholesterol drugs to lower their risk of heart attack or stroke, statins to reduce so-called bad cholesterol, and another class to boost so-called good cholesterol, known as HDL. But, yesterday ...

Cholesterol Drug Clinical Trial Halted, No Cardiovascular BenefitsFriday, May 27, 2011 @ 4:47PMA clinical trial of a blood lipid treatment involving niacin, or vitamin B3, has been stopped 18 months early because it did not reduce the risk of cardiovascular events like strokes and heart attacks.

Interim analysis of AIM-HIGH study affirms positive impact of Niaspan on HDL and triglyceride lipid valuesFriday, May 27, 2011 @ 11:00AMThe National Heart, Lung and Blood Institute (NHLBI), a division of the National Institutes of Health (NIH), today disclosed results from an interim analysis of the AIM-HIGH clinical trial.

A.M. Vitals: Abbott’s Niaspan Setback May Reverberate With MerckFriday, May 27, 2011 @ 7:57AMAlso: combining military and VA electronic health records; HIV treatment irony; inadvertent TB exposure at Emory.